Neurodiagnostic Holdings LLC
How we got $2.6M
Based on 16 employees on its 2025 401(k) filing.
What we know
Estimated value over time
▲ 53% since 2020Today's estimate scaled by the headcount reported each year and that year's prices. A trend, not a record of past sale values.
Employees over time
▲ 23% since 2020Show as table
| Year | Source | Employees | Est. revenue |
|---|---|---|---|
| 2020 | Form 5500 | 13 | $2.4M |
| 2021 | Form 5500 | 15 | $2.8M |
| 2022 | Form 5500 | 15 | $2.8M |
| 2023 | Form 5500 | 13 | $2.4M |
| 2024 | Form 5500 | 13 | $2.4M |
| 2025 | Form 5500 | 16 | $2.9M |
Participants are employees in the company's retirement plan at year end, from its Form 5500 filing with the Department of Labor. They usually run a little under total headcount (part-timers and new hires may not be eligible). Revenue and EBITDA apply this industry's revenue per employee and margin to each year's count.
Compared with similar businesses nearby
| Business | Est. revenue | Distance |
|---|---|---|
| NEURODIAGNOSTIC HOLDINGS LLC this business | $3.8M | — |
| Deaconess Family Care West Hefner Oklahoma City | $1.8M | 0.1 mi |
| Waddah Nassar, MD Oklahoma City | $1.8M | 0.1 mi |
| Susan Ogden, APRN Oklahoma City | $1.8M | 0.1 mi |
| Dr. Terry D. Holt, Md Oklahoma City | $1.8M | 0.4 mi |
| Dr. Darrin L. Webster, Do Oklahoma City | $1.8M | 0.4 mi |
| Access Urgent Care Oklahoma City | $1.8M | 0.4 mi |
The full calculation
Figures are shown toward the upper part of their range rather than at its middle.
Brought up to date: prices are 10% higher than in the benchmark's year, both included above.
| Estimated value = EBITDA × typical sale multiple | $2.6M |
| Multiple for this size and industry | 3.8× |
| Value range | $1.3M – $3.8M |
| Employees in its retirement plan (2025 Form 5500) | 16 |
| Industry revenue per employee | $184K |
| Revenue = employees × revenue per employee | $3.8M |
| EBITDA margin (industry, adjusted for size) | 18% |
| EBITDA = revenue × margin | $679K |
Uses the newest headcount we have: participants in the company's retirement plan from its Form 5500 filing with the Department of Labor. Plans can leave out part-timers and new hires, so the range leans higher than the estimate.
| Revenue range | $2.5M – $4.7M |
| EBITDA range | $443K – $831K |
| Industry (NAICS) | Medical and Diagnostic Laboratories (621510) |
EBITDA margin: from IRS tax returns of S corporations in this industry (2019–2022), adjusted for company size: smaller companies typically run higher margins. EBITDA here is after owners' salaries.
Benchmarks: US Economic Census 2022, OK. These are statistical estimates, not reported financials. Listing details come from the company's Form 5500 retirement-plan filing. Full methodology
About Neurodiagnostic Holdings LLC
Neurodiagnostic Holdings LLC is a medical and diagnostic laboratories company in Oklahoma City, Oklahoma. Its estimated annual revenue is about $3.8M, with roughly $679K of EBITDA. It has about 16 employees. Its estimated business value is $2.6M (likely range $1.3M–$3.8M).
Common questions
- Who owns Neurodiagnostic Holdings LLC?
- The owner of Neurodiagnostic Holdings LLC isn't in public records we've found yet. If you own or run the business, you can add or correct its details on SeeBITDA.
- How much revenue does Neurodiagnostic Holdings LLC make?
- SeeBITDA estimates Neurodiagnostic Holdings LLC's annual revenue at about $3.8M (likely between $2.5M and $4.7M), based on public records such as its PPP loan and retirement-plan filings, brought up to 2026.
- What is Neurodiagnostic Holdings LLC worth?
- About $2.6M, roughly 3.8× its estimated EBITDA of $679K, typical for a medical and diagnostic laboratories company its size. Likely range: $1.3M–$3.8M.
- How many employees does Neurodiagnostic Holdings LLC have?
- About 16, from its 2025 retirement-plan filing.